Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
Study Type: Treatment
Phase: II
NCTID: NCT03581292
Principal Investigator:
Kevin Ginn
Hypofractionated radiation therapy for patients with breast cancer receiving regional nodal irradiation.
The OVAL Study: A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec VB-111 Combined with Paclitaxel vs. Paclitaxel Combined with Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
A Double Blind, Placebo Controlled Dose Range Finding Study to Assess the Safety, Pharmacokinetics, and Efficacy of Tempol for the Reduction of Severe Mucositis in Head and Neck Cancer Patients Undergoing Combined Radio- and Chemotherapy
Study Type: Treatment
Phase: II
NCTID: NCT03480971
Principal Investigator:
Chris Lominska
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab Mk-3475, Nsc 776864 in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Study Type: Treatment
Phase: II
NCTID: NCT03834961
Principal Investigator:
Keith August
Exosomal as correlative biomarker in Clinical Outcomes in Patients Undergoing Neoadjuvant Chemoradiation therapy for Rectal Cancer
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors DAWT and Relapsed Favorable Histology Wilms Tumors FHWT
Study Type: Treatment
Phase: II
NCTID: NCT04322318
Principal Investigator:
Keith August